Hims & Hers Health, Inc.

NYSE:HIMS

Medical - Equipment & Services

Healthcare
$17.05 +3.47%

+$1.11 today

Market cap
$3.85B
Beta
2.40
P/E (TTM)
-569.3
EPS (TTM)
-$0.06
52W Low $13.74High $70.43

Volume 9.53M

Average 26.18M

HIMS Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Hims & Hers Health, Inc.NYSE: HIMS

Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026

Cost of revenue growth accelerates

Q3 FY2026 cost of revenue of $381.17M rose 142.9% year over year, ahead of the +105.4% change in trailing-twelve-month cost of revenue. Sequentially, it rose 39.9% from the prior quarter. Over 3 fiscal years it compounded at +73.2% a year.

Context

  • Cost of revenue amounted to 26.2% of revenue in FY2025, up 5.6 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +142.9% holds above the trailing-twelve-month pace of +105.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$381.17M+39.9% QoQ
Last fiscal yearDec 2025
$614.26M+102.5% YoY
LTMSep 2026
$1.13B+105.4% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+142.9%——
1 year+102.5%——
3-year CAGR+73.2%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
614.26M USD
Year-over-year change
+102.5%
4-year CAGR
+73.8%

Cost of Revenue vs competitors

How HIMS compares with its peers on the latest reported figures

  • HIMS's LTM Sep 2026 cost of revenue of $1.13B is the 6th highest of the 10 companies compared; the peer median is $1.24B.
  • Its year-over-year change of +105.4% is the highest of 10, against a peer median of -0.5%.
  • Cost of revenue amounts to 39.5% of revenue for HIMS, versus a peer median of 41.7%.
HIMS Competitors Peer median
Cost of Revenue for HIMS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KVUEKenvue Inc.LTM Sep 2026$6.48B +3.1%-1.7%41.7%
ELThe Estée Lauder Companies Inc.LTM Sep 2026$3.66B -1.8%-6.9%24.0%
PRGOPerrigo Company plcLTM Jun 2026$2.77B -0.5%-2.7%66.7%
COTYCoty Inc.LTM Sep 2026$2.39B +16.1%+2.4%41.2%
EPCEdgewell Personal Care CompanyLTM Mar 2026$1.24B -2.6%+0.2%59.0%
HIMSHims & Hers Health, Inc.LTM Sep 2026$1.13B +105.4%+73.2%39.5%
HELEHelen of Troy LimitedLTM Feb 2026$970.6M -2.3%-6.1%54.3%
ELFe.l.f. Beauty, Inc.LTM Jun 2026$450.46M +14.4%+36.5%25.6%
HNSTThe Honest Company, Inc.LTM Mar 2026$232.81M -2.6%+3.8%66.1%
LFMDLifeMD, Inc.LTM Mar 2026$30.96M +10.1%+28.2%14.1%
Peer median (excluding HIMS) $1.24B-0.5%+0.2%41.7%

Competitors are the stored peer set for HIMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue271.88M526.92M872M1.48B2.35B
Cost of Revenue67.38M118.19M157.05M303.38M614.26M
Gross Profit204.49M408.72M714.95M1.17B1.73B
Gross Margin75.2%77.6%82.0%79.5%73.8%
Research & Development22.38M29.24M48.23M78.82M149.3M
Selling, General & Admin249.56M370.78M576.32M846.61M1.19B
Operating Expenses319.54M477.42M744.4M1.11B1.63B
Depreciation & Amortization4.08M7.47M9.52M17.09M54.5M
EBITDA(106.72M)(58.24M)(12.06M)88.8M178.43M
EBITDA Margin-39.3%-11.1%-1.4%6.0%7.6%
Operating Income(115.04M)(68.7M)(29.45M)61.9M105.61M
Operating Margin-42.3%-13.0%-3.4%4.2%4.5%
Interest Income00000
Interest Expense00000
Other Income / Expenses4.25M2.99M7.88M9.81M18.31M
Income Before Tax(110.8M)(65.71M)(21.57M)71.71M123.92M
Pre-Tax Margin-40.8%-12.5%-2.5%4.9%5.3%
Income Tax Expense(3.14M)(31K)1.98M(54.33M)(4.44M)
Net Income(107.66M)(65.68M)(23.55M)126.04M128.37M
Net Margin-39.6%-12.5%-2.7%8.5%5.5%
EPS (Basic)(0.58)(0.32)(0.11)0.580.57
EPS (Diluted)(0.58)(0.32)(0.11)0.530.51
Weighted Avg Shares186.78M204.52M209.34M215.94M224.96M
Weighted Avg Shares (Diluted)186.78M204.52M209.34M236.81M258.23M

Hims & Hers Health, Inc.

NYSE:HIMS

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.